Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Fluorometholone

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44339   clinical trials with a EudraCT protocol, of which   7369   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    Study title:
    Active substance: FLUOROMETHOLONE
    Study summary document link (including results): Fluorometholone_EUdraCT_reduced datafields for Interim publi.xls
    View full study record
    Document reference: 47211
    Study title: A prospective study on ocular hypertensive and antiinflammatory response to different dosages of fluorometholone in children. Fan DS, Ng JS, Lam DS. Ophthalmology. 2001 Nov;108(11):1973-7. Comment in: Ophthalmology. 2003 Jun;110(6):1072-3; author reply 1073. PMID: 12799226.
    Active substance: FLUOROMETHOLONE
    Study summary document link (including results): A prospective study on ocular hypertensive.pdf
    View full study record
    Document reference: 28257
    Study title: Efficacy of nedocromil 2% versus fluorometholone 0.1%: a randomised, double masked trial comparing the effects on severe vernal keratoconjunctivitis. Tabbara KF, al-Kharashi SA. Br J Ophthalmol. 1999 Feb;83(2):180-4.
    Active substance: FLUOROMETHOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 28258
    Study title: Ocular-hypertensive and anti-inflammatory response to rimexolone therapy in children. Fan DS, Yu CB, Chiu TY, Wong CY, Ng JS, Pang CP, Lam DS. Arch Ophthalmol. 2003 Dec;121(12):1716-21.
    Active substance: FLUOROMETHOLONE
    Study summary document link (including results): Ocular-hypertensive and anti-inflammatory response.pdf
    View full study record
    Document reference: 28255
    Study title: Ocular-hypertensive response to topical steroids in children. Kwok AK, Lam DS, Ng JS, Fan DS, Chew SJ, Tso MO. Ophthalmology. 1997 Dec;104(12):2112-6.
    Active substance: FLUOROMETHOLONE
    Study summary document link (including results): Ocular-hypertensive response to topical steroids in children.pdf
    View full study record
    Document reference: 28259
    Study title: The role of aspirin in vernal keratoconjunctivitis. Anwar MS. J Coll Physicians Surg Pak. 2003 Mar;13(3):178-9.
    Active substance: FLUOROMETHOLONE
    Study summary document link (including results): The role of aspirin in vernal keratoconjunctivitis.pdf
    View full study record
    Document reference: 28256
    Study title:
    Active substance: FLUOROMETHOLONE AND GENTAMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 28261
    Study title: Ruiz Alvez, M et al. Medical report of the clinical comparative study with 0.3% Gentamicin and 0.1% Fluorometholone eye drops in comparison with 0.35% Neomicine and 0.1% Fluorometholone eye drops in therapy of bacterial conjunctivitis. May 18, 1989. (age range 4-76 years)
    Active substance: FLUOROMETHOLONE AND GENTAMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 28260
    Study title: A pilot assessor blind crossover randomised comparison of the relative efficacies of nedocromil sodium 2% eyes drops 1 drop QDS and fluorometholone 0,1% eye drops QDS in the treatment of vernal keratoconjunctivitis - Professor KF Tabbara et al. - 08/12/1996
    Active substance: NEDOCROMIL
    Study summary document link (including results): Nedocromil-Study 1.pdf
    View full study record
    Document reference: 46997
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun Jun 01 20:00:26 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA